Podcast 26 Sep 2025What’s next in immunology & inflammation R&D: The trends to watch This week’s guest is Joseph Ferner of Inpart, the author of a new R&D Trends Report on Immunology and Inflammation. Together we discussed the research landscape September 26, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 22 Aug 2025 The Sanofi pipeline in 2025: Is the play-to-win strategy working? Find out what Sanofi has been up to in 2025, especially as it just closed the Opella deal and is now expanding its pipeline. August 22, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 May 2025 Nine promising small molecule drug discovery companies to look out for in 2025 Discover nine small molecule drug discovery companies that have raised funding for their novel medicines in the last year. May 16, 2025 - 13 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 13 Jan 2025 2025 predictions: Which trends are set to shape the biotech industry this year? From AI to gene therapy, we reached out to industry experts to get their thoughts on the trends that will shape the biotech industry in 2025. January 13, 2025 - 18 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 27 Dec 2024[Rebroadcast] The power of natural killer cells December 27, 2024 Share WhatsApp Twitter Linkedin Email Listen Now More
Best in Biotech 19 Nov 2024 Six bispecific antibody companies you should know about Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients. November 19, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Nov 2024 8 biotech companies advancing new treatments for breast cancer in 2024 Delve into the diverse landscape of breast cancer treatment with nine biotech companies currently developing new treatments. November 14, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 5 Nov 2024 From consumer health to pure biopharma: Inside Sanofi’s strategic shift Delve into Sanofi’s “play to win” strategy as investments are ramping up after their consumer health division’s divestment. November 5, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 1 Nov 2024The immunometabolism landscape To talk about immunometabolism, our guest on the podcast this week is CEO of Sitryx Therapeutics, Iain Kilty. November 1, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Reports 25 Sep 2024Current trends & innovations in 3D organoids Discover how 3D organoids are already shaping research & drug development today and explore their future potential. September 25, 2024 Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Sep 2024 Six immunology biotech companies revolutionizing immune treatments in 2024 Find out more about six immunology companies that have recently raised impressive funds in the biotech industry. September 19, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 27 Aug 2024 Could microbiome drugs be the key to unlocking checkpoint inhibitors’ potential? As Microbiotica announces phase 1 approval for two microbiome drugs we delve into their potential in oncology and beyond. August 27, 2024 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email